MYCOBUTIN Drug Patent Profile
✉ Email this page to a colleague
When do Mycobutin patents expire, and when can generic versions of Mycobutin launch?
Mycobutin is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MYCOBUTIN is rifabutin. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the rifabutin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mycobutin
A generic version of MYCOBUTIN was approved as rifabutin by LUPIN LTD on February 24th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYCOBUTIN?
- What are the global sales for MYCOBUTIN?
- What is Average Wholesale Price for MYCOBUTIN?
Summary for MYCOBUTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 11 |
Patent Applications: | 5,091 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MYCOBUTIN |
What excipients (inactive ingredients) are in MYCOBUTIN? | MYCOBUTIN excipients list |
DailyMed Link: | MYCOBUTIN at DailyMed |
![MYCOBUTIN drug patent expirations Drug patent expirations by year for MYCOBUTIN](/p/graph/s/t/MYCOBUTIN-patent-expirations.png)
![Drug Prices for MYCOBUTIN](/p/graph/drug-price/MYCOBUTIN.png)
Recent Clinical Trials for MYCOBUTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Bari | Phase 3 |
Cadrock Pty. Ltd. | Phase 2 |
Centre for Digestive Diseases, Australia | Phase 2 |
Pharmacology for MYCOBUTIN
Drug Class | Rifamycin Antimycobacterial |
US Patents and Regulatory Information for MYCOBUTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MYCOBUTIN | rifabutin | CAPSULE;ORAL | 050689-001 | Dec 23, 1992 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |